[ACRV] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[ACRV] Acrivon Therapeutics, Inc. Common Stock
Announcement Date
28-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -33.08%
YoY- -143.30%
Quarter Report
ACRV's Result
ACRV's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 1,884 0 0 0 -
PBT -22,441 -18,798 -16,486 -19,252 -14,466 -13,914 -12,756 45.58%
Tax 0 0 181 1,770 -133 7 -1,637 -
NP -22,441 -18,798 -16,486 -19,252 -14,466 -13,914 -11,119 59.50%
Tax Rate - - - - - - - -
Total Cost 22,441 18,798 16,486 21,136 14,466 13,914 11,119 59.50%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -1,021.87 0.00 0.00 0.00 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.59 -0.52 -0.73 -0.86 -0.66 -0.63 -0.51 10.17%
EPS Diluted -0.59 -0.52 -0.73 -0.86 -0.66 -0.63 -0.51 10.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.